Timothy M. Janetos

Timothy M. Janetos

Auto-generated profile, based on publicly available information

Timothy M. Janetos

Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2019 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
ECErika M. Cornell
Erika M. Cornell
TJTimothy M. Janetos
Timothy M. Janetos
SXShuai Xu
Shuai Xu

5 April 2023 in The American Journal of Pathology
Verified
Journal Article
Closed access
TJTimothy M. Janetos
Timothy M. Janetos
NZNancy Zakaria
Nancy Zakaria
DGDebra A. Goldstein
Debra A. Goldstein

19 September 2023 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
FPFrancesco Pichi
Francesco Pichi
SSScott D. Smith
Scott D. Smith
DGDebra A. Goldstein
Debra A. Goldstein
DBDina Baddar
Dina Baddar
TGTerese K.A. Gerges
Terese K.A. Gerges
PNPiergiorgio Neri
Piergiorgio Neri

1 June 2022 in Chinese Clinical Oncology
Verified
Journal Article
Open access
PDF file
TJTimothy M. Janetos
Timothy M. Janetos
NVNicholas J. Volpe
Nicholas J. Volpe
SSShira S. Simon
Shira S. Simon
Background and Objective: Neuro-ophthalmic manifestations of cancer are vast and early recognition of a serious ocular condition due to either cancer or its therapy is important for both vision preservation as well as providing valuable treatment and prognostic information regarding the underlying malignancy. This review focuses on direct and indirect effects of cancer on the eye and its adnexa, hematologic malignancy, complications of traditional and novel oncologic therapies, and paraneoplastic syndromes as they relate to the eye as these disorders can lead to potentially devastating or irreversible vision loss. Methods: PubMed was searched primarily for the following topics: optic nerve infiltration, primary vitreoretinal lymphoma (PVRL), ocular paraneoplastic disorders, and ophthalmic complications of cancer therapeutics. Literature was selected based on historical significance and landmark studies (e.g., Cross et al. series of paraneoplastic optic neuritis patients; Chan’s textbook on primary intraocular lymphoma) as well as publications published after 2000. References from select studies were additionally included. Given the sparsity of literature on many subjects, most publications were included during this time frame in our review. Key Content and Findings: There are several ophthalmic entities that the oncologist should be aware of including leukemic optic nerve infiltration, PVRL, paraneoplastic syndromes as they related to the eye, and adverse effects of therapeutics. Unfortunately, given the rarity of some of these entities [e.g., paraneoplastic optic neuropathy (PON), cancer-associated retinopathy (CAR)], diagnosis can be difficult and treatment options are often limited. Conclusions: Oncologists can develop a set of basic ophthalmology examination skills that will help to triage and manage patient eye complaints. In certain instances, oncologists have the potential to avert devastating vision loss with early recognition of neuro-ophthalmic complications.

15 July 2025 in American Journal of Ophthalmology
Verified
Journal Article
Open access
MAMassimo Accorinti
Massimo Accorinti
MBMeghan K. Berkenstock
Meghan K. Berkenstock
MCMaria Vittoria Cicinelli
Maria Vittoria Cicinelli
JDJanet Davis
Janet Davis
ADAlejandra de-la-Torre
Alejandra de-la-Torre
ASAriel Schlaen
Ariel Schlaen
The clinical utility of multimodal imaging for diagnosis and management of non-infectious posterior uveitis. Advances in multimodal imaging support amendment of the imaging strategies in the authoritative classification criteria published by the Standards of Uveitis Nomenclature II in 2021. Peer-reviewed electronic search in OVID MEDLINE, Embase, Cochrane, Scopus, last accessed August 6, 2024. Medical literature published from January 1, 2018, to July 12, 2024, for the primary analysis and from 2012-2017 inclusive for the secondary analysis. Independent reviewers extracted data using the Covidence Systematic Review Tool and assessed quality and bias with the Mixed Methods Assessment Tool, followed by a consensus process. Statements of imaging findings and clinical utility were tabulated. Main outcome measures were: (1) factual imaging findings for acute posterior multifocal placoid pigment epitheliopathy (APMPPE), birdshot chorioretinitis, multifocal choroiditis, punctate inner choroidopathy, multifocal evanescent white dot syndrome (MEWDS) and serpiginous choroiditis. Imaging modalities included color fundus (CFP), autofluorescence (FAF), OCT, fluorescein angiography (FA), indocyanine green angiography (ICGA) and OCT angiography; (2) subjective or objective statements of clinical utility for diagnosis, detection of activity, monitoring, or detection of complications. The level of evidence was evaluated using the GRADE process. 70 studies from 2018-2024 met inclusion criteria and quality standards for study type. Combined with 63 foundational studies from 2012-2017, there were 292 specific imaging statements based on imaging examinations of 6537 patients in the primary analysis. There were 124 statements of clinical utility, with OCT or OCTA accounting for 66/124 (53%), plus an additional 29 statements of clinical utility for multimodal imaging (MMI). Evidence was ranked high for OCT on at least one outcome measure for each disease, followed by CFP, FAF, and FA in 4 of 5 diseases (80%), OCTA in 3 of 5 (60%), and ICGA in 1 of 5 (20%). Substantial information exists regarding the imaging findings in noninfectious posterior uveitis. Expert opinions generally favor the clinical utility of MMI. Additional research with efficient imaging strategies and objective outcome measures is warranted. Revision of current classification guidelines should be considered. Protocol registration CRD42024576867 with PROSPERO (https://crd.york.ac.uk/prospero/).

22 November 2018 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
TJTimothy M. Janetos
Timothy M. Janetos
LALisa Akintilo
Lisa Akintilo
SXShuai Xu
Shuai Xu